Skip to content

Ultrasound-guided Transmuscular Quadratus Lumborum Block for Percutaneous Nephrolithotomy

Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Percutaneous Nephrolithotomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02818140
Enrollment
60
Registered
2016-06-29
Start date
2016-07-31
Completion date
2018-03-31
Last updated
2018-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone

Keywords

Postoperative pain, Transmuscular quadratus lumborum block, Block, Ropivacaine, TQL, percutaneous nephrolithotomy, PNL, Ultrasound-guided

Brief summary

Patients undergoing percutaneous nephrolithotomy (PNL) suffer from acute postoperative pain, despite a multimodal analgesic regime. We hypothesize that active (ropivacaine) transmuscular quadratus lumborum (TQL) block will significantly reduce postoperative opioid consumption and pain following PNL operation compared with placebo (saline) TQL block. The aim of this study is to investigate the effect of ultrasound-guided (USG) TQL block concurrent with a multimodal analgesic regime compared to the multimodal analgesic regime alone (and placebo TQL block) in a randomized and placebo controlled design.

Detailed description

Patients undergoing percutaneous nephrolithotomy (PNL) suffer from acute postoperative pain, despite a multimodal analgesic regime, and the patients receive considerable amounts of long lasting opioids. For the patients this greatly increase the risk of experiencing the adverse effects of opioids. The ultrasound-guided (USG) transmuscular quadratus lumborum (TQL) block is a single dosage of local anesthetic (LA) delivered in the plane between the psoas major muscle and the quadratus lumborum muscle. LA spreads cephalad into the thoracic paravertebral space to reach the somatic ventral rami (intercostal nerves) and the thoracic sympathetic trunk. The TQL block can reduce visceral pain and pain originating from the abdominal wall and has an expected duration of analgesic efficacy of 24 hours. The aim of this study is to investigate the efficacy of the active USG TQL block together with the multimodal analgesic regime to reduce postoperative opioid consumption and pain compared to placebo USG TQL block and the multimodal analgesic regime in a randomized and placebo controlled design.

Interventions

PROCEDURERopivacaine TQL block

Unilateral ultrasound-guided TQL block with 30 mL ropivacaine 0.75% 30 min prior to the surgical procedure

PROCEDURESaline TQL block

Unilateral ultrasound-guided TQL block with 30 mL of saline 0,9% 30 min prior to the surgical procedure

DRUGRopivacaine
DRUGSaline
DEVICEUltrasound

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Scheduled for elective PNL operation in general anaesthesia with propofol and remifentanil. Received oral and written information about the trial Signed the informed consent American Society of Anesthesiologists (ASA) classification 1-3

Exclusion criteria

Cannot cooperate Does not speak or understand Danish Allergy towards drugs used in the trial Large daily consumption of opioids Known alcohol or drug abuse Difficulty or inability to visualize the relevant muscular or fascial structures necessary to perform the USG-TQL block Pregnancy \-

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption6 hours postoperativelyMorphine consumption in the first 6 hours postoperatively - data from PCA pump and patient medical record

Secondary

MeasureTime frameDescription
Pain score at rest (NRS 0-10/10)15 min, 30 min, 1 h, 2h, 4h, 6h, 12h, 18h, 24 hours postoperativelyPain score NRS
Pain score at sitting position (NRS 0-10/10)15 min, 30 min, 1 h, 2h, 4h, 6h, 12h, 18h, 24 hours postoperativelyPain score NRS
Total morphine consumption15 min, 30 min, 1 h, 2h, 4h, 6h, 12h, 18h, 24 hours postoperativelyData from PCA pump and patient electronic file
Opioid side effects (nausea, vomiting)0-24 hours postoperativelyPONV, number of episodes, antiemetics
NRS score during application of the TQL block (NRS 0-10/10)intraoperativeProcedure discomfort
Time to first ambulation - get out of bed0-24 hours postoperativelyTime to first ambulation from bed to walk on the floor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026